2,000
Participants
Start Date
September 1, 2016
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2030
RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
RECRUITING
Winship Cancer Institute, Emory
RECRUITING
Mayo Clinic, Jacksonville
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
The Ohio State University, Columbus
RECRUITING
University of Southern California (USC), Los Angeles
RECRUITING
Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
RECRUITING
Peter MacCallum Cancer Center, Melbourne
NOT_YET_RECRUITING
Maisonneuve-Rosemont Hospital / University of Montreal, Montreal
RECRUITING
The Ottawa Hospital, Ottawa
RECRUITING
Mount Sinai / Princess Margaret, Toronto
RECRUITING
Institut Curie, Paris
NOT_YET_RECRUITING
University Medical Center and Medical Faculty Mannheim, University of Heidelberg, Mannheim
RECRUITING
Ludwig Maximilian University, Munich
RECRUITING
Veneto Institute of Oncology, Padua
RECRUITING
Ospedale Borgo Roma, Verona
RECRUITING
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw
RECRUITING
Institute of Oncology Ljubljana, Ljubljana
NOT_YET_RECRUITING
Samsung Medical Center, Seoul
NOT_YET_RECRUITING
"Hospital Clinico Universitario Virgen de la Arrixaca", Murcia
RECRUITING
University Hospital Birmingham (Queen Elizabeth), Birmingham
RECRUITING
Royal Marsden Hospital, London
TransAtlantic Retroperitoneal Sarcoma Working Group
UNKNOWN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OTHER